We believe that the results of our study on BRCA2, the relationship of which with lymph node metastasis has not been agreed upon and the association with clinicopathologic parameters has not yet been sufficiently investigated, will make a significant contribution to the literature. This evidence concerns the gene BRCA2 and metastatic malignant neoplasm in the lymph nodes.